• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Generic acetaminophen recalled for labeling error

Article

IVAX Pharmaceuticals is recalling certain lots of 500-mg acetaminophen tablets and capsules because there's an error on the product label. The label incorrectly states, "Do not exceed 12 tablets or capsules in a 24-hour period," when it should have said, "Do not exceed 8 tablets or capsules in 24 hours."

Generic acetaminophen recalled for labeling error

IVAX Pharmaceuticals is recalling certain lots of 500-mg acetaminophen tablets and capsules because there's an error on the product label. The label incorrectly states, "Do not exceed 12 tablets or capsules in a 24-hour period," when it should have said, "Do not exceed 8 tablets or capsules in 24 hours." Although no serious illnesses or injuries have been reported at this time, a patient who takes more than eight 500-mg tablets or capsules in a 24-hour period may increase the risk of liver toxicity. The recall affects Goldline brand Extra Strength Genapap 500-mg Caplets and Tablets and Extra Strength Genebs 500-mg Caplets and Tablets. For more information, call 1-(866) 262-1243 or visit http://www.fda.gov/medwatch/safety/2006/safety06.htm#Goldline.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.